Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 3
1991 3
1992 3
1993 3
1994 4
1995 8
1996 11
1997 8
1998 5
1999 1
2000 2
2001 2
2002 5
2003 4
2004 4
2005 7
2006 12
2007 8
2008 3
2009 7
2010 7
2011 10
2012 8
2013 12
2014 7
2015 6
2016 12
2017 5
2018 6
2019 10
2020 9
2021 7
2022 12
2023 7
2024 4
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Results by year

Filters applied: . Clear all
Page 1
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
Teerlink JR, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon SD, Adams KF, Anand I, Arias-Mendoza A, Biering-Sørensen T, Böhm M, Bonderman D, Cleland JGF, Corbalan R, Crespo-Leiro MG, Dahlström U, Echeverria LE, Fang JC, Filippatos G, Fonseca C, Goncalvesova E, Goudev AR, Howlett JG, Lanfear DE, Li J, Lund M, Macdonald P, Mareev V, Momomura SI, O'Meara E, Parkhomenko A, Ponikowski P, Ramires FJA, Serpytis P, Sliwa K, Spinar J, Suter TM, Tomcsanyi J, Vandekerckhove H, Vinereanu D, Voors AA, Yilmaz MB, Zannad F, Sharpsten L, Legg JC, Varin C, Honarpour N, Abbasi SA, Malik FI, Kurtz CE; GALACTIC-HF Investigators. Teerlink JR, et al. N Engl J Med. 2021 Jan 14;384(2):105-116. doi: 10.1056/NEJMoa2025797. Epub 2020 Nov 13. N Engl J Med. 2021. PMID: 33185990 Free article. Clinical Trial.
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
Hoeper MM, Al-Hiti H, Benza RL, Chang SA, Corris PA, Gibbs JSR, Grünig E, Jansa P, Klinger JR, Langleben D, McLaughlin VV, Meyer GMB, Ota-Arakaki J, Peacock AJ, Pulido T, Rosenkranz S, Vizza CD, Vonk-Noordegraaf A, White RJ, Chang M, Kleinjung F, Meier C, Paraschin K, Ghofrani HA, Simonneau G; REPLACE investigators. Hoeper MM, et al. Lancet Respir Med. 2021 Jun;9(6):573-584. doi: 10.1016/S2213-2600(20)30532-4. Epub 2021 Mar 24. Lancet Respir Med. 2021. PMID: 33773120 Clinical Trial.
Spontaneous hemopneumothorax.
Tatebe S, Kanazawa H, Yamazaki Y, Aoki E, Sakurai Y. Tatebe S, et al. Ann Thorac Surg. 1996 Oct;62(4):1011-5. doi: 10.1016/0003-4975(96)00445-6. Ann Thorac Surg. 1996. PMID: 8823081
Impact of Sodium-Glucose Co-Transporter-2 Inhibitors on Exercise-Induced Pulmonary Hypertension.
Satoh T, Yaoita N, Higuchi S, Nochioka K, Yamamoto S, Sato H, Tatebe S, Yamada K, Yamada Y, Komaru K, Chiba N, Sarashina Y, Mori R, Nakada M, Hayashi H, Suzuki H, Takahama H, Ota H, Yasuda S. Satoh T, et al. Among authors: tatebe s. Pulm Circ. 2024 Dec 15;14(4):e70026. doi: 10.1002/pul2.70026. eCollection 2024 Oct. Pulm Circ. 2024. PMID: 39678732 Free PMC article.
Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START).
Koizumi W, Kim YH, Fujii M, Kim HK, Imamura H, Lee KH, Hara T, Chung HC, Satoh T, Cho JY, Hosaka H, Tsuji A, Takagane A, Inokuchi M, Tanabe K, Okuno T, Ogura M, Yoshida K, Takeuchi M, Nakajima T; JACCRO and KCSG Study Group. Koizumi W, et al. J Cancer Res Clin Oncol. 2014 Feb;140(2):319-28. doi: 10.1007/s00432-013-1563-5. Epub 2013 Dec 24. J Cancer Res Clin Oncol. 2014. PMID: 24366758 Free PMC article. Clinical Trial.
Chronic thromboembolic pulmonary hypertension and schizophrenia.
Suzuki H, Sugimura K, Tatebe S, Aoki T, Shimokawa H. Suzuki H, et al. Among authors: tatebe s. Int J Cardiol. 2016 Mar 15;207:363-4. doi: 10.1016/j.ijcard.2016.01.010. Epub 2016 Jan 7. Int J Cardiol. 2016. PMID: 26820368 No abstract available.
Randomized phase II trial of first-line treatment with tailored irinotecan and S-1 therapy versus S-1 monotherapy for advanced or recurrent gastric carcinoma (JFMC31-0301).
Komatsu Y, Takahashi Y, Kimura Y, Oda H, Tajima Y, Tamura S, Sakurai J, Wakasugi T, Tatebe S, Takahashi M, Sakata Y, Kitajima M, Sakamoto J, Saji S. Komatsu Y, et al. Among authors: tatebe s. Anticancer Drugs. 2011 Jul;22(6):576-83. doi: 10.1097/CAD.0b013e328345b509. Anticancer Drugs. 2011. PMID: 21512394 Free article. Clinical Trial.
211 results